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MPreoperative C-reactive protein levels to predict early and late
mortalities after coronary artery bypass surgery: Eight years
of follow-up
Albert H. M. van Straten, MD,a Mohamed A. Soliman Hamad, MD,a Andre´ J. van Zundert, MD, PhD,
FRCA,b,d Elisabeth J. Martens, PhD,c,e Jacques P. A. M. Scho¨nberger, MD, PhD,a and
Andre M. de Wolf, MD, PhDf
Objective: There is limited evidence that increased preoperative levels of C-reactive protein are associated with
increased mortality after coronary artery bypass grafting. We retrospectively investigated in 5669 patients the pre-
dictive value of preoperative C-reactive protein levels for early and late mortalities after coronary artery bypass
grafting.
Methods: Patients undergoing isolated coronary artery bypass grafting between January 2000 and December
2007 (n ¼ 8500) were studied. Preoperative demographic data and risk factors and outcome data (mortality
data) were prospectively collected in a database. Preoperative C-reactive protein levels were retrieved from the
laboratory data.
Results: In 5669 of 8500 cases, the preoperative C-reactive protein level could be retrieved. Seventy-five patients
were unavailable for follow-up. A preoperative C-reactive protein level greater than 10 mg/L was an independent
risk factor for early mortality, whereas a level greater than 5 mg/L was a risk factor for late mortality. Other risk
factors were age, sex, chronic obstructive pulmonary disease, diabetes, left ventricular ejection fraction less than
35%, peripheral vascular disease, and previous cardiac surgery. We found a higher mean C-reactive protein value
in patients with a left ventricular ejection fraction less than 35% (18.5  33 mg/L) than in those with an ejection
fraction greater than 35% (P< .0001).
Conclusions: Preoperative C-reactive protein levels can be used in risk stratification in coronary artery bypass
grafting surgery. A C-reactive protein level greater than 10 mg/L is a risk factor for early mortality, whereas a level
greater than 5 mg/L is a risk factor for late mortality.Increased levels of C-reactive protein (CRP) are associated
with increased incidences of coronary and cardiac events
after percutaneous coronary intervention.1 For patients
with chronic heart failure, CRP level is a major prognostic
factor.2
A few reports have addressed the correlations between
elevated preoperative levels of CRP and early3 and late4
mortalities after coronary artery bypass grafting (CABG).
In one study, a correlation was found between elevated
CRP level and early graft occlusion.5 We investigated
whether elevated preoperative CRP level is associated with
From the Departments of Cardio-Thoracic Surgery,a Anesthesiology,b and Education
and Research,c Catharina Hospital–Brabant Medical School, Eindhoven, The Neth-
erlands; the Department of Anesthesiology, University Hospital Ghent,d Ghent,
Belgium; the Center of Research on Psychology in Somatic Diseases, Department
of Medical Psychology, Tilburg University,e Tilburg, The Netherlands; and the
Department of Anesthesiology, The Feinberg School of Medicine,f Northwestern
University, Chicago, Ill.
Received for publication Dec 10, 2008; revisions received March 23, 2009; accepted
for publication March 29, 2009; available ahead of print June 24, 2009.
Address for reprints: Mohamad A. Soliman Hamad, MD, Department of Cardiotho-
racic Surgery, Catharina Hospital, Michelangelolaan 2, Postbus 1350, 5602 ZA
Eindhoven, The Netherlands (E-mail: aasmsn@cze.nl).
J Thorac Cardiovasc Surg 2009;138:954-8
0022-5223/$36.00
Copyright  2009 by The American Association for Thoracic Surgery
doi:10.1016/j.jtcvs.2009.03.050954 The Journal of Thoracic and Cardiovascular Surhigher early and late mortalities in a large patient population
undergoing isolated CABG.
MATERIALS AND METHODS
Patients
This study analyzed the data of patients who underwent isolated CABG
between January 2000 and December 2007 at a single center. Since 2000,
we have been able to measure preoperative CRP levels at our hospital.
Clinical data, including demographic characteristics and risk factors, were
prospectively collected and placed in a database. Preoperative CRP levels
were retrieved from the laboratory data bank. This study was performed
with permission from the local medical ethics committee.
Operative Techniques
All patients received short-acting anesthetic drugs to facilitate early
extubation. Extracorporeal circulation was performed with normothermic,
nonpulsatile flow. Cold crystalloid cardioplegia (St Thomas’ Hospital
solution) or warm blood cardioplegia was used to induce and maintain car-
dioplegic arrest, according to the surgeon’s preference. All patients under-
going CABG with the use of extracorporeal circulation received a low
dose of aprotinin (2 million kallikrein inactivating unit during extracorpo-
real circulation, administered in the prime solution. Patients undergoing
off-pump surgery did not receive any aprotinin.
Preoperative CRP Levels
Preoperative CRP levels were retrieved from the laboratory data bank.
Values below 6 mg/L were reported as ‘‘CRP<6,’’ making analysis ofgery c October 2009
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MAbbreviations and Acronyms
CABG ¼ coronary artery bypass grafting
COPD ¼ chronic obstructive pulmonary disease
CRP ¼ C-reactive protein
LVEF ¼ left ventricular ejection fraction
PVD ¼ peripheral vascular disease
CRP as a continuous variable difficult. We therefore converted a report
of ‘‘CRP<6’’ into a value of 5 in all analyses looking at continuous CRP
levels. For most analyses, patients were grouped into 4 groups according
to CRP level: group 1, which included those with CRP levels less than
6 mg/L; group 2, which included those with CRP levels between 6 and
10 mg/L; group 3, which included those with CRP levels between 11 and
30 mg/L; and group 4, which included those with CRP levels greater than
30 mg/L. Group 5 was added to include patients with an unknown preoper-
ative CRP level. Because in our laboratory a CRP value less than 6 mg/L,
reported as 5 mg/L, is considered abnormal, 6 mg/L was used as a cutoff
value in several analyses studying preoperative CRP levels as a dichotomous
variable. We chose 3 arbitrary values to divide patients with abnormal CRP
levels into different groups and to examine whether the degree of elevation
of CRP is correlated with the prognosis. The value of 10 mg/L was used as
a cutoff point in the study of Biancari and colleagues,3 and the value of 30
mg/L was used by Milazzo and associates.6
Follow-up
Follow-up data concerning mortality were gathered from databases of
health insurance companies. The data of 9% of the total patient group could
initially not be retrieved from these databases. We therefore contacted the
general practitioners by telephone for information on mortality data of those
patients. For the remaining patients, we contacted the city authorities of the
cities in which the patients lived at the time of the operation. Early mortality
was defined as death from any cause within 30 postoperative days, whereas
late mortality was defined as death from any cause later than 30 postopera-
tive days.
Statistical Analyses
Discrete variables were compared with the c2 test and are presented as
numbers and percentages. Continuous variables were compared with analy-
sis of variance and t test and are presented as meanSD. Univariate and mul-
tivariate logistic regression analyses and Cox proportional hazard regression
analyses (entry procedure) were performed to investigate the impact of bio-
medical variables on early and late mortalities, respectively. Comparison of
long-term survival between the different groups was performed with the Wil-
coxon–Gehan test. Univariate analyses were used to test for the potentially
confounding effects of biomedical and demographic factors on outcome.
If significant at P<.05, confounders were included in the multivariable re-
gression analyses. The cumulative incidences of death in CRP groups were
estimated according to the Kaplan–Meier method, comparing differences be-
tween groups with the log-rank test. The zero time point indicates the time of
CABG. Hazard ratios with 95% confidence intervals are reported. All statis-
tical analyses were performed with SPPS software (Statistical Product and
Services Solutions, version 15.0; SPSS Inc, Chicago, Ill).
RESULTS
Between January 2000 and December 2007, a total of
8500 patients underwent isolated CABG in our center. In
5669 cases, a preoperative CRP level could be retrieved
from the laboratory data bank. Of the 8500 patients, fol-
low-up data was incomplete for 75, resulting ultimately inThe Journal of Thoracic and C5625 patients with both a measured preoperative CRP level
and a complete follow-up. Mean follow-up was 1394 858
days, with a median of 1373 days. Demographic and clinical
data stratified according to preoperative CRP group are
listed in Table 1. Patients with elevated CRP levels were
more often older and female and more frequently had
chronic obstructive pulmonary disease (COPD), poor left
ventricular ejection fraction (LVEF), peripheral vascular
disease (PVD), low creatinine clearance, and a history of
preoperative myocardial infarction.
Early and late mortalities stratified according to preopera-
tive CRP level are shown in Table 2. Early mortality in-
creased with increasing preoperative CRP level. For early
mortality, the difference between groups 1 and 2 was not sig-
nificant (P ¼ .408); all other between-group comparisons
were significant (P< .05 for all). For late mortality, only
the differences between group 1 and groups 2, 3, and 4
were statistically significant. The late mortality in group 5
was high. Most of the missing preoperative CRP values
were those of patients included in the early phase of the study.
In Table 3, we show the survivals of each group after 1
and 5 years. With regard to 5-year survival, all differences
between groups were statistically significant except for those
between groups 2 and 5 and between group 3 and 5.
Univariate logistic regression analyses revealed preopera-
tive CRP level as a risk factor for early mortality both as a con-
tinuous variable and as a dichotomous variable with a cutoff
value of 6 mg/L (Table 4). Other patient-related risk factors
that were identified included age, COPD, diabetes, LVEF
less than 35%, PVD, low creatinine clearance, previous
cardiac surgery, and emergency operations. Sex, hyperten-
sion, and the use of extracorporeal circulation were not found
to be risk factors for early mortality. Complications, such as
perioperative myocardial infarction, perioperative use of
intra-aortic balloon pump, and reexploration, were also iden-
tified as risk factors for early mortality.
All preoperative risk factors that were identified with uni-
variate logistic regression analyses were entered into the
multivariate logistic regression model. Preoperative CRP
level as a continuous variable did prove to be an independent
risk factor for early mortality. Other independent risk factors
were age, COPD, diabetes, LVEF lower than 35%, PVD,
low creatinine clearance, and previous cardiac surgery.
Emergency operation did not prove to be an independent
risk factor. When the preoperative CRP level as a dichoto-
mous parameter with a cutoff point of 6 mg/L was entered
in a multivariate model using the same variables, it was
also an independent risk factor.
Results of Cox regression analyses for risk factors of late
mortality are shown in Table 5. Univariate analyses revealed
preoperative CRP level as a risk factor for late mortality,
both as a continuous variable and as a dichotomous variable
with a cutoff value of 6 mg/L. Furthermore, patient-related
risk factors that were identified included age, sex, COPD,ardiovascular Surgery c Volume 138, Number 4 955
Perioperative Management van Straten et al
P
MTABLE 1. Demographic and clinical data stratified according to preoperative C-reactive protein concentration
Group 1
(n ¼ 3698)
Group 2
(n ¼ 778)
Group 3
(n ¼ 823)
Group 4
(n ¼ 370)
Group 5
(n ¼ 2831) P value
Age (y, mean  SD) 64.2  9.5 64.6  9.6 65.8  9.2 66.9  8.7 65.1  9.6 <.0001
Male (no.) 2960 (80.0%) 586 (75.3%) 605 (73.5%) 278 (75.1%) 2130 (75.2%) <.0001
Hypertension (no.) 1613 (43.6%) 361 (46.4%) 400 (48.6%) 172 (46.5%) 1189 (42.0%) .006
Chronic obstructive pulmonary
disease (no.)
402 (10.9%) 104 (13.4%) 140 (17.0%) 62 (16.8%) 365 (12.9%) <.0001
Diabetes (no.) 785 (21.2%) 180 (23.1%) 199 (24.2%) 84 (22.7%) 615 (21.7%) .359
Left ventricular
ejection fraction<35% (no.)
81 (2.3%) 29 (3.8%) 34 (4.3%) 24 (6.7%) 113 (4.2%) <.0001
Peripheral vascular
disease (no.)
382 (10.3%) 98 (12.6%) 133 (16.2%) 64 (17.3%) 320 (11.3%) <.0001
Creatinine clearance
(mL/min, mean  SD)
75.5  25.4 75.3  27.6 73.6  29.7 70.9  30.3 72.3  26.8 <.0001
Preoperative myocardial
infarction (no.)
1402 (38.3%) 328 (42.9%) 369 (45.4%) 186 (51.4%) 1247 (44.8%) <.0001
Previous coronary
artery bypass grafting (no.)
174 (4.7%) 38 (4.9%) 32 (3.9%) 24 (6.5%) 166 (5.9%) .071
Off-pump surgery (no.) 425 (11.5%) 95 (12.2%) 80 (9.7%) 39 (10.5%) 302 (10.7%) .435
Grafts placed (mean  SD) 3.4  1.1 3.4  1.1 3.5  1.0 3.5  1.0 3.3  1.1 <.0001
Emergency operation (no.) 37 (1.0%) 10 (1.3%) 16 (1.9%) 16 (4.3%) 249 (8.8%) <.0001
Perioperative myocardial
infarction (no.)
87 (2.4%) 25 (3.2%) 22 (2.7%) 11 (3.0%) 91 (3.2%) .276
Reexploration (no.) 161 (4.4%) 44 (5.7%) 43 (5.2%) 19 (5.1%) 156 (5.5%) .229
Use of intra-aortic
balloon pump (no.)
36 (1.0%) 10 (1.3%) 18 (2.2%) 14 (3.8%) 91 (3.2%) <.0001
Group 1, C-reactive protein<6 mg/L; Group 2, C-reactive protein 6–10 mg/L;Group 3, C-reactive protein 11–30 mg/L; Group 4, C-reactive protein>30 mg/L;Group 5, C-reactive
protein unknown.diabetes, LVEF lower than 35%, PVD, low creatinine clear-
ance, history of preoperative myocardial infarction, previous
cardiac surgery, number of grafts, use of extracorporeal cir-
culation, emergency operation, and hypertension. Compli-
cations, such as perioperative myocardial infarction,
perioperative use of intra-aortic balloon pump, and reexplo-
ration, were also identified as risk factors for late mortality.
All preoperative risk factors that were identified with uni-
variate analyses were entered into the multivariate Cox re-
gression model. Preoperative CRP level as a continuous
variable was an independent risk factor for late mortality.
Age, sex, COPD, diabetes, LVEF lower than 35%, PVD,
low creatinine clearance, history of preoperative myocardial
infarction, previous cardiac surgery, and emergency opera-
tion were also independent predictors of late mortality.
TABLE 2. Early and late mortalities stratified according to
preoperative C-reactive protein concentration
C-reactive protein Early mortality Late mortality
<6 mg/L (group 1, n ¼ 3698) 52 (1.4%) 217 (5.8%)
6–10 mg/L (group 2, n ¼ 778) 15 (1.9%) 80 (10.1%)
11–30 mg/L (group 3, n ¼ 823) 33 (4.3%) 88 (11.5%)
>30 mg/L (group 4, n ¼ 370) 27 (7.2%) 38 (10.2%)
Unknown (group 5, n ¼ 2831) 128 (2.6%) 747 (15.5%)
P value <.0001 <.0001956 The Journal of Thoracic and Cardiovascular SurUse of extracorporeal circulation and hypertension were
not identified as independent risk factors. Preoperative
CRP level also proved to be a risk factor when entered as
a dichotomous parameter with a cutoff point of 6 mg/L in
a multivariate model with the same variables.
Survival according to the Kaplan Meyer method stratified
according to preoperative CRP level is plotted in Figure 1.
Log-rank test showed the differences to be statistically signif-
icant (overall P < .0001). Differences observed between
groups 1 through 4 were all significant (all P< .05), with the
exception of the difference between groups 3 and 4 (P¼ .151).
The relationship between LVEF and preoperative CRP
level is shown in Table 6. Patients with impaired preopera-
tive LVEF (<35%) had higher preoperative CRP levels
(P ¼ .0001).
TABLE 3. Survivals at 1 and 5 years stratified according to
preoperative C-reactive protein concentration
C-reactive protein 1-y survival 5-y survival
<6 mg/L (group 1, n ¼ 3698) 96.1%  0.3% 89.3%  0.7%
6–10 mg/L (group 2, n ¼ 778) 93.7%  0.9% 84.5%  1.7%
11–30 mg/L (group 3, n ¼ 823) 89.1%  1.2% 77.8%  2.2%
>30 mg/L (group 4, n ¼ 370) 84.8%  2.1% 73.3%  3.5%
Unknown (group 5, n ¼ 2831) 92.5%  0.4% 84.0%  0.6%
P value <.0001 <.0001gery c October 2009
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Univariate Multivariate
Risk factor Hazard ratio
95% Confidence
interval P value Hazard ratio
95% Confidence
interval P value
Preoperative C-reactive protein* 1.017 1.013–1.022 <.0001 1.013 1.007–1.019 <.0001
Age* 1.082 1.065–1.099 <.0001 1.056 1.026–1.087 .001
Chronic obstructive pulmonary disease 1.91 1.41–2.60 <.0001 1.67 1.05–2.64 .029
Diabetes 1.48 1.12–1.96 .005 1.63 1.08–2.47 .020
Left ventricular ejection fraction<35% 6.02 4.18–8.68 <.0001 3.52 1.88–6.61 <.0001
Peripheral vascular disease 1.60 1.15–2.23 .005 1.49 0.92–2.42 .102
Creatinine clearance* 0.971 0.966–0.976 <.0001 0.980 0.971–0.990 <.0001
Previous coronary artery bypass grafting 4.26 3.11–5.83 <.0001 2.98 1.64–5.41 <.0001
Emergency operation 6.94 4.94–9.32 <.0001 2.32 0.89–5.99 .082
Perioperative myocardial infarction 5.79 3.97–8.43 <.0001
Reexploration 5.78 4.27–7.82 <.0001
Intra-aortic balloon pump 14.96 10.52–20.52 <.0001
Preoperative C-reactive protein>5 mg/Ly 2.86 2.00–4.10 <.0001 2.36 1.58–3.53 <.0001
Male 0.77 0.58–1.02 .069
Hypertension 0.94 0.73–1.21 .659
No. of grafts placed* 0.912 0.817–1.017 .099
Preoperative myocardial infarction 1.12 0.92–1.37 .227
*Entered as a continuous variable. yEntered as a dichotomous variable with a cutoff point of 6 mg/L in a separate multivariate model from that used for C-reactive protein as a con-
tinuous variable.DISCUSSION
In this study, it was confirmed that preoperative CRP level
is an independent risk factor for early and late mortalities
after CABG, as has been shown by others.3,4 CRP is an
acute-phase protein, and elevated levels may be an indication
of an underlying infectious disease or other inflammatory
process. Every patient was investigated for underlying dis-The Journal of Thoracic and Cease before surgery. If any sign of infection was found, the
operation was postponed unless the cardiac condition did
not allow this. This is the reason that emergency operations
were more frequent in the group of patients with a CRP level
of more than 30 mg/L than in groups with lower CRP levels,
as shown in Table 1. Thus we may assume that in elective
cases no evident signs of infectious disease were present.P
MTABLE 5. Predictors of late mortality (>30 days after coronary artery bypass grafting): Univariate and multivariate Cox regression analyses
Univariate Multivariate
Risk factor Hazard ratio
95% Confidence
interval P value Hazard ratio
95% Confidence
interval P value
Preoperative C-reactive protein* 1.010 1.008–1.013 <.0001 1.007 1.004–1.010 <.0001
Age* 1.090 1.082–1.097 <.0001 1.063 1.049–1.078 <.0001
Chronic obstructive pulmonary disease 1.91 1.68–2.18 <.0001 1.70 1.42–2.07 <.0001
Diabetes 1.68 1.49–1.88 <.0001 1.71 1.42–2.07 <.0001
Left ventricular ejection fraction<35% 3.16 2.61–3.81 <.0001 2.30 1.64–3.22 <.0001
Peripheral vascular disease 2.14 1.88–2.45 <.0001 1.71 1.38–2.14 <.0001
Creatinine clearance* 0.975 0.973–0.977 <.0001 0.986 0.982–0.992 <.0001
Preoperative myocardial infarction 1.29 1.19–1.40 <.0001 1.18 1.03–1.35 .016
Previous coronary artery bypass grafting 1.97 1.68–2.31 <.0001 1.92 1.42–2.61 <.0001
Off-pump surgery 0.67 0.53–0.86 .001 1.19 0.83–1.72 .330
No. of grafts placed* 1.055 1.009–1.104 .019 1.199 0.832–1.729 .677
Emergency operation 2.09 1.73–2.53 <.0001 2.07 1.20–3.55 .01
Hypertension 1.16 1.04–1.29 .004 1.07 0.90–1.29 .414
Perioperative myocardial infarction 2.51 2.02–3.12 <.0001
Reexploration 2.07 1.74–2.45 <.0001
Intra-aortic balloon pump 3.77 3.07–4.63 <.0001
Preoperative C-reactive proteiny 2.20 1.86–2.60 <.0001 1.79 1.50–2.14 <.0001
Male 0.84 0.75–0.951 .005 1.28 1.03–1.58 .021
*Entered as a continuous variable. yEntered as a dichotomous variable with a cutoff point of 6 mg/L in a separate multivariate model from that used for C-reactive protein as a con-
tinuous variable.ardiovascular Surgery c Volume 138, Number 4 957
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MElevated levels of CRP were still found in some patients.
Only since 2004 have we routinely measured preoperative
CRP in every case. We are therefore missing CRP values
for patients who were operated on in the early years of the
study. This explains why the group of patients with missing
values had a higher risk for late mortality than did the groups
with low CRP levels. Because these patients were operated
on in the early portion of the experience, the follow-up period
has been longer and thus the chance for late mortality higher.
We still considered it worthwhile to include patients from
this early period to clarify the impact of preoperative CRP
levels on late mortality.
There was no difference in early mortality between groups
1 and 2. Further increases in preoperative CRP did increase
the risk of early mortality. This suggests that a cutoff value
of 10 mg/L is probably a good indicator for increased risk
of early mortality. For late mortality, preoperative CRP level
was an independent risk factor when it was used as a contin-
uous variable indication, with risk increasing with CRP level.
Importantly, log-rank test showed no difference between
group groups 3 and 4, indicating that a further increase in
preoperative CRP beyond 30 mg/L does not further increase
the risk of late mortality. It seems remarkable that even
a small increase in preoperative CRP level (6–10 mg/L)
proved to be a risk factor for late mortality. The predictive
value of CRP for recurrent cardiovascular events and death
has been established previously among patients with docu-
mented coronary artery disease.7 A recent study8 has shown
FIGURE 1. Survival stratified according to preoperative C-reactive pro-
tein (CRP) concentration in milligrams per liter (Kaplan–Meier plots)958 The Journal of Thoracic and Cardiovascular Suthat patients with increased CRP level undergoing CABG
have an increased long-term risk of cardiovascular events.
This could explain the poorer long-term survival of these
patients. Interestingly, elevated CRP levels were found in
patients with a low LVEF, a finding confirmed by others.4,5
Study Limitations
First, this was not a prospective randomized study, which
warrants caution in our conclusions. Second, in our institu-
tion a CRP level lower than 6 mg/L is reported only as
‘‘<6 mg/L,’’ thus limiting the use of CRP level as a contin-
uous variable as discussed previously. One of the most im-
portant limitations of this study is the number of missing
CRP values in the early years. We tried to overcome this
problem by using proper statistical tools.
CONCLUSIONS
In conclusion, preoperative CRP levels can be used in risk
stratification in CABG, with a level greater than 10 mg/L as
a risk factor for early mortality and a level greater than 5 mg/
L as a risk factor for late mortality. A prospective study
might show whether postponing the operation could influ-
ence the prognosis for this group of patients.
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